Pfizer signs agreement with UN-backed group expanding access to COVID-19 pill to low-and middle-income countries but Doctors Without Borders says deal does not go far enough

Simon Ateba( Chief White House Correspondent )

Simon Ateba is Chief White House Correspondent for Today News Africa. Simon covers President Joe Biden, Vice President Kamala Harris, the U.S. government, the United Nations, the International Monetary Fund, the World Bank and other financial and international institutions in Washington D.C. and New York City.

Pfizer Inc. (NYSE: PFE) and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to life-saving medicines for low- and middle-income countries, on Tuesday, announced that they had signed a deal that would allow other drug manufacturers to replicate its experimental COVID-19 pill. Fewer than one percent of Pfizer’s COVID-19 shots have gone to poorer countries.